Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease

Spina, Salvatore, La Joie, Renaud, Petersen, Cathrine, Nolan, Amber L, Cuevas, Deion, Cosme, Celica, Hepker, Mackenzie, Hwang, Ji-Hye +12 more·2021·Brain

Cited by (278)

Items 101–200 of 278

  1. Amyloid-β modulates the phase separation and aggregation of α-synuclein
    Alexander Röntgen, Zenon Toprakcioglu, Owen M. Morris, Michele Vendruscolo · 2025 · Proceedings of the National Academy of Sciences
  2. Pathology‐specific patterns of cerebellar atrophy in neurodegenerative disorders
    Yu Chen, Salvatore Spina, Patrick M. Callahan, Lea T. Grinberg, William W. Seeley, Howard J. Rosen, Joel H. Kramer, Bruce L. Miller, Katherine P. Rankin · 2023 · Alzheimer s & Dementia
  3. Pathways underlying selective neuronal vulnerability in Alzheimer's disease: Contrasting the vulnerable locus coeruleus to the resilient substantia nigra
    Alexander J. Ehrenberg, Cathrine Sant, Felipe Luiz Pereira, Song Hua Li, Jessica Buxton, Sonali Langlois, Marena I. Trinidad, Ian Michael Oh, Renata Elaine Paraízo Leite, Roberta Diehl Rodriguez et al. · 2025 · Alzheimer s & Dementia
  4. Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer’s disease
    Alberto Benussi, Federica Agosta, Alba Rosa Alfano, Antonio Antico, Giuseppe Bellelli, Laura Bonanni, Gabriella Bottini, Marco Bozzali, Ovidio Brignoli, Giuseppe Bruno et al. · 2025 · Neurological Sciences
  5. Alzheimer's disease
    Alberto Serrano‐Pozo, Valentina Escott‐Price, Lea T. Grinberg, Tharick Ali Pascoal, Marc Suárez‐Calvet, Bruno Dubois, Reisa Anne Sperling · 2026 · The Lancet
  6. Sex and gender differences in dementia
    Patrick Salwierz, Carly Davenport, Vishaal Sumra, M. Florencia Iulita, Maria Teresa Ferretti, Maria Carmela Tartaglia · 2022 · International review of neurobiology
  7. DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers
    Daniela Jimenez-Harrison, Carol J. Huseby, Claire N. Hoffman, Steven Sher, Dalton T. Snyder, Brayden Seal, Chunhua Yuan, Hongjun Fu, Vicki Hopper Wysocki, Flaviano Giorgini et al. · 2023 · Biochemistry
  8. Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease
    Andre Direito Goulart Leitao, Rijwan Uddin Ahammad, Brian J. Spencer, Chengbiao Wu, Eliezer Masliah, Robert A. Rissman · 2023 · Neurobiology of Disease
  9. Angiotensin II‐mediated hippocampal hypoperfusion and vascular dysfunction contribute to vascular cognitive impairment in aged hypertensive rats
    Olivia J. Gannon, Sarah M. Tremble, Conor McGinn, Ruby Guth, Nadia Scoppettone, Ryan D. Hunt, Kirtika Prakash, Abbie Chapman Johnson · 2023 · Alzheimer s & Dementia
  10. The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatments
    Hwan‐Ching Tai, Haou-Tzong Ma, Shien-Chieh Huang, Meng‐Fang Wu, Chia‐Lin Wu, Yen‐Ting Lai, Zhong‐Lin Li, Richard A. Margolin, Anthony J. Intorcia, Geidy E. Serrano et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Neuropathological Heterogeneity of Dementia Due to Combined Pathology in Aged Patients: Clinicopathological Findings in the Vallecas Alzheimer’s Reina Sofía Cohort
    Iván Burgueño‐García, María José López-Martínez, Alicia Uceda‐Heras, Lucía García‐Carracedo, María Ascensión Zea‐Sevilla, Héctor Rodrigo-Lara, I. Rego-García, Laura Saiz-Aúz, Paloma Ruiz-Valderrey, Francisco Javier López‐González et al. · 2024 · Journal of Clinical Medicine
  12. Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts
    Julien Lagarde, Piyush Maiti, Daniel R. Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone, Isabel Elaine Allen, David N. Soleimani‐Meigooni et al. · 2025 · Annals of Neurology
  13. Neuropathologic Changes of Alzheimer’s Disease and Related Dementias: Relevance to Future Prevention
    Lon R. White, María M. Corrada, Claudia H. Kawas, Brenna Cholerton, Steve E. Edland, Margaret E. Flanagan, Thomas Jude Montine · 2023 · Journal of Alzheimer s Disease
  14. Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implications
    Keith A. Vossel, Emily L. Johnson, Benjamin Cretin, Riki Matsumoto · 2026 · The Lancet Neurology
  15. Exploring the Role of Glycolytic Enzymes PFKFB3 and GAPDH in the Modulation of Aβ and Neurodegeneration and Their Potential of Therapeutic Targets in Alzheimer’s Disease
    Imran Ahmad, Ranjana Singh, Saurabh Pal, Soni Prajapati, Nidhi Sachan, Yusra Laiq, Hadiya Husain · 2023 · Applied Biochemistry and Biotechnology
  16. The unique neuropathological vulnerability of the human brain to aging
    Isidró Ferrer · 2023 · Ageing Research Reviews
  17. Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
    William G. Mantyh, J. Nicholas Cochran, Jared W. Taylor, Iris Broce, Ethan G. Geier, Luke W. Bonham, Ashlyn G. Anderson, Daniel W. Sirkis, Renaud La Joie, Leonardo Iaccarino et al. · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  18. Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions
    Pauline Maillard, Evan M. Fletcher, Owen Thomas Carmichael, Christopher G. Schwarz, Stephan Seiler, Charles S DeCarli, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  19. α-Synuclein seed amplification assay positivity beyond synucleinopathies
    Iván Martínez-Valbuena, Sarah Fullam, Seán O’Dowd, Maria Carmela Tartaglia, Gábor Géza Kovács · 2025 · EBioMedicine
  20. Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer’s disease: a series of clinical cases
    Nick Corriveau‐Lecavalier, Mary M. Machulda, Hugo Botha, Jonathan Graff‐Radford, David S. Knopman, Val J. Lowe, Julie A. Fields, Nikki H. Stricker, Bradley F. Boeve, Clifford R. Jack et al. · 2022 · Journal of Neurology
  21. Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease
    Anna Bartoletti‐Stella, Martina Elena Tarozzi, Giacomo Mengozzi, Francesca Asirelli, Laura Brancaleoni, Nicola Mometto, Michelangelo Stanzani Maserati, Simone Baiardi, Simona Linarello, Marco Spallazzi et al. · 2022 · Frontiers in Aging Neuroscience
  22. Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217
    Breton Michael Asken, Rosie E. Curiel, Elizabeth Crocco, Melissa J. Armstrong, Shellie-Anne T. Levy, Franchesca Arias, Mónica Rosselli, Idaly Vélez-Uribe, Warren Barker, Emily F. Matusz et al. · 2025 · The Journal of Prevention of Alzheimer s Disease
  23. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
    Annie G. Bryant, Mary Kate Manhard, David H. Salat, Bruce Robert Rosen, Bradley T. Hyman, Keith A. Johnson, Susie Y. Huang, Rachel E. Bennett, Yi‐Fen Yen · 2021 · Current Alzheimer Research
  24. Association of [ 18 F]Flortaucipir–PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders
    Agathe Vrillon, Salvatore Spina, Jhony Alejandro Mejía‐Perez, Tia LaMore, Claire Yballa, David N. Soleimani‐Meigooni, Ganna Blazhenets, Adam L. Boxer, Julio C. Rojas, Argentina Lario Lago et al. · 2026 · Neurology
  25. Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
    Leonardo Iaccarino, Jorge J. Llibre‐Guerra, Eric McDade, Lauren Edwards, Brian Andrew Gordon, Tammie L.S. Benzinger, Jason J. Hassenstab, Joel H. Kramer, Yan Li, Bruce L. Miller et al. · 2024 · Brain Communications
  26. Can neurodevelopmental disorders influence the course of neurodegenerative diseases? A scoping review
    Perrine Laury Marie Siguier, Mélanie Planton, Éloïse Baudou, Yves Chaix, A Delage, Marie Rafiq, Marie Wolfrum, Fleur Gérard, Mélanie Jucla, Jérémie Pariente · 2024 · Ageing Research Reviews
  27. Comorbid neuropathology and atypical presentation of Alzheimer's disease
    Stefanie Danielle Piña‐Escudero, Renaud La Joie, Salvatore Spina, Ji‐Hye Hwang, Zachary Miller, Eric Jinsheng Huang, Harli E. Grant, Nidhi S. Mundada, Adam L. Boxer, Maria‐Luisa Gorno‐Tempini et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  28. Dissociable spatial topography of cortical atrophy in early‐onset and late‐onset Alzheimer's disease: A head‐to‐head comparison of the LEADS and ADNI cohorts
    Yuta Katsumi, Alexandra Touroutoglou, Michael J. Brickhouse, Ani Eloyan, Ryan Eckbo, Alexander Zaitsev, Renaud La Joie, Julien Lagarde, Daniel R. Schonhaut, Maryanne Thangarajah et al. · 2025 · Alzheimer s & Dementia
  29. Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co‐pathologies, and sex differences
    Elliot Keats Shwab, Gita A. Pathak, Joshua Harvey, Michaël E. Belloy, Corinne Eleanor Fischer, Michael William Lutz, Sonja W. Scholz, Noah Cook, Danielle Marie Reid, Jingchun Chen et al. · 2025 · Alzheimer s & Dementia
  30. Parkinson Disease Neuropathological Comorbidities: Prevalences from Younger-Old to Older-Old, With Comparison to Non-Demented, Non-Parkinsonian Subjects
    Thomas G. Beach, Geidy E. Serrano, Erika D. Driver‐Dunckley, Lucia I. Sue, Holly A. Shill, Shyamal H. Mehta, Christine M. Belden, Ileana Lorenzini, Cécilia Tremblay, Parichita Choudhury et al. · 2025 · medRxiv
  31. Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes
    Diego Sepúlveda Falla, Carlos Andrés Villegas‐Lanau, Charles L. White, Geidy E. Serrano, Juliana Acosta‐Uribe, Bárbara Mejía‐Cupajita, Nelson David Villalba‐Moreno, Pinzhang Lu, Markus Glatzel, Julia Kofler et al. · 2024 · Journal of Neuropathology & Experimental Neurology
  32. α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment
    Diana Esteller, Agnès Pérez‐Millan, Jordi Sarto, Roger Puey, N. Guillén Soley, Adrià Tort‐Merino, Neus Falgàs, Sergi Borrego‐Écija, Gerard Piñol‐Ripoll, Miquel Massons et al. · 2025 · Neurology
  33. The NIA-AA revised clinical criteria for Alzheimer’s disease: are they too advanced?
    Angelo Bianchetti, Manubu Ikeda, Raimundo Mateos, Sara Mondini, Kiran Rabheru, Carlo Serrati, Diego De Leo · 2023 · International Psychogeriatrics
  34. Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
    Alexandre Bejanin, Nicolas Villain · 2024 · The Lancet Neurology
  35. Treatment of Alzheimer’s disease by combination of acupuncture and Chinese medicine based on pathophysiological mechanism: A review
    Zhao Liu, Ruiqian Guan, Fan Bu, Limin Pan · 2022 · Medicine
  36. Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease
    Philipp Arndt, Malte Pfister, Valentina Perosa, Hendrik Mattern, Jose Bernal, Anna-Charlotte John, Marc Dörner, Patrick Müller, Ruediger Christian Braun-Dullaeus, Cornelia Garz et al. · 2025 · Journal of Neurology
  37. Alpha‐synuclein co‐pathology in Down syndrome‐associated Alzheimer's disease
    Alexander Maximilian Bernhardt, Íñigo Rodríguez‐Baz, Ibán Aldecoa, Javier Arranz, José Enrique Arriola‐Infante, Lucía Maure‐Blesa, María Carmona‐Iragui, Sebastian Longen, Svenja Verena Trossbach, Armin Giese et al. · 2025 · Alzheimer s & Dementia
  38. Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathology
    Laia Montoliu‐Gaya, Elizabeth Valeriano-Lorenzo, Nicholas James Ashton, Francisco Javier López‐González, Juan Lantero‐Rodriguez, Alicia Ruiz-González, Ana Belén Pastor, Belén Frades, María Ascensión Zea‐Sevilla, Meritxell Valentí et al. · 2025 · Alzheimer s & Dementia
  39. Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
    Michelle Diane Rudman, Jason D. Ulrich, David M. Holtzman · 2026 · Cell
  40. Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands
    Praveen P. N. Rao, Arash Shakeri, Yusheng Zhao, Frédéric Calon · 2021 · European Journal of Medicinal Chemistry
  41. Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer’s Disease
    Mario Merlini, Elif G. Sözmen, Keshav S. Subramanian, Alissa L. Nana, William W. Seeley, Katerina Akassoglou · 2022 · Methods in molecular biology
  42. Voxel-based Morphometry of Alzheimer’s Disease Using a Localizer Image: A Comparative Study with Magnetization Prepared Rapid Acquisition with Gradient Echo
    Shohei Inui, Daita Kaneda, Keita Sakurai, Yuto Uchida, Osamu Abe, Yoshio Hashizume · 2024 · Magnetic Resonance in Medical Sciences
  43. Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
    Vaishnavi Jadhav, Jade G. Stair, Randall J. Eck, Samuel N. Smukowski, Heather N. Currey, Laura García‐Toscano, Joshua C. Hincks, Caitlin S. Latimer, Paul N. Valdmanis, Brian C. Kraemer et al. · 2024 · Neurobiology of Disease
  44. Lessons from genetic studies in Alzheimer disease
    Gaël Nicolas · 2024 · Revue Neurologique
  45. TDP-43 Promotes Amyloid-Beta Toxicity by Delaying Fibril Maturation via Direct Molecular Interaction
    Adam J. Gatch, Feng Ding · 2024 · ACS Chemical Neuroscience
  46. Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer’s Disease Over a 25-Year Period in an Academic Brain Bank
    Jordi Sarto, Gerard Mayà, Laura Molina‐Porcel, Mircea Balasa, Ellen Gelpí, Ibán Aldecoa, Sergi Borrego‐Écija, José Contador, Teresa Ximelis, Miguel Vergara et al. · 2022 · Journal of Alzheimer s Disease
  47. Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer’s Disease Neuropathologic Spectrum
    Arenn F. Carlos, Mary M. Machulda, Matthew H. Rutledge, Aivi T. Nguyen, Robert Ross Reichard, Matthew Baker, Rosa Rademakers, Dennis W. Dickson, Ronald Carl Petersen, Keith A. Josephs · 2023 · Journal of Alzheimer s Disease
  48. Contribution of alpha‐synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI
    Samir Abu‐Rumeileh, G Arajyan, Eric M. Reiman, Markus Otto, Christopher M. Weise, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  49. Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
    D. Luke Fischer, Marissa A. Menard, Omar Z. Abdelaziz, Nicholas M. Kanaan, Virginia G. Cobbs, Richard Kennedy, Geidy E. Serrano, Thomas G. Beach, Laura A. Volpicelli‐Daley · 2025 · Acta Neuropathologica Communications
  50. Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference
    Neus Falgàs, Lucía Maure‐Blesa, Beau M. Ances, Lisi Flores Aguilar, Sigan L. Hartley, Jason J. Hassenstab, M. Florencia Iulita, Matthew P. Janicki, Katherine A. Koenig, Patrick J. Lao et al. · 2025 · Alzheimer s & Dementia
  51. Facets of language performance in early‐onset and late‐onset Alzheimer's disease dementia
    Jeanne Gallée, Laura E. Gibbons, Seo‐Eun Choi, Michael L. Lee, Phoebe Scollard, Emily H. Trittschuh, Jesse B Mez, Andrew J. Saykin, Nancy S. Foldi, Shubhabrata Mukherjee et al. · 2025 · Alzheimer s & Dementia
  52. The behavioral variant of Alzheimer’s disease does not show a selective loss of Von Economo and phylogenetically related neurons in the anterior cingulate cortex
    Ellen H. Singleton, Yolande A.L. Pijnenburg, Priya Gami‐Patel, Baayla D.C. Boon, Femke H. Bouwman, Janne M. Papma, Harro Seelaar, Philip Scheltens, Lea T. Grinberg, Salvatore Spina et al. · 2022 · Alzheimer s Research & Therapy
  53. Clinical and metabolic imaging features of late‐onset and early‐onset posterior cortical atrophy
    Valeria Isella, Daniele Licciardo, Giulia Nastasi, Valentina Impagnatiello, Francesca Ferri, Cristina Mapelli, Cinzia Crivellaro, Monica Musarra, Sabrina Morzenti, Ildebrando Marco Appollonio et al. · 2022 · European Journal of Neurology
  54. Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology
    Baayla D.C. Boon, Irene Frigerio, Danae de Gooijer, Tjado H. J. Morrema, John G. J. M. Bol, Yvon Galis, Martijn W. Heymans, Netherlands Brain Bank, Melissa Erin Murray, Normal Aging Brain Collection Amsterdam et al. · 2024 · Neuropathology and Applied Neurobiology
  55. Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer’s Disease
    Chiara Giuseppina Bonomi, Caterina Motta, Martina Gaia Di Donna, Martina Poli, Marzia Nuccetelli, Sergio Bernardini, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana · 2024 · Alzheimer s Research & Therapy
  56. Lack of difference between amyloid‐beta burden at gyral crests and sulcal depths in diverse neurodegenerative diseases
    Shojiro Ichimata, Ain Kim, Naoki Nishida, Gábor Géza Kovács · 2022 · Neuropathology and Applied Neurobiology
  57. Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer’s Disease Dementia: Evidence for Dependency on Alzheimer’s Disease Neuropathological Changes
    Diego Sepúlveda Falla, Carlos Andrés Villegas‐Lanau, Charles L. White, Geidy E. Serrano, Juliana Acosta‐Uribe, Bárbara Mejía‐Cupajita, Nelson David Villalba‐Moreno, Pinzhang Lu, Markus Glatzel, Julia Kofler et al. · 2023 · medRxiv
  58. Health Behavior Change to Mitigate Dementia Risk: An Updated Review
    Victoria E. Sanborn, Jennifer Duncan Davis, Laura Elizabeth Korthauer · 2024 · Current Geriatrics Reports
  59. Neuropathological comorbidity, genetics and cognition in a Chinese community-based autopsy cohort
    Wei Wu, Xue Wang, Yuan-Yuan Xu, Chao Ma, Xiao-Jing Qian, Wen-Ying Qiu · 2025 · Brain : a journal of neurology
  60. Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
    Sophie E Mastenbroek, Lyduine Eisa Collij, Jacob W. Vogel, Serena Caldera, Geidy E. Serrano, Charles H. Adler, Claudia Marina Vargiu, Sebastian Palmqvist, Frederik Barkhof, Piero Parchi et al. · 2025 · Nature Communications
  61. Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
    Jie Wu, Chaofan Geng, Liyang Liu, Yi Tang · 2025 · Medicine Plus
  62. Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data
    Lydia Trudel, J. Therriault, A. Macedo, S. A. Hosseini, J. Fernandez-Arias, T. Chan, N. Rahmouni, G. Bezgin, C. Tissot, Marcel S. Woo et al. · 2026 · Brain : a journal of neurology
  63. Establishing tau-PET cut-points for cognitive diagnosis with 18F-PI-2620 in a multi-ethnoracial cohort
    Victoria R. Tennant, Koral V Wheeler, Noelle N. Lee, Jamie A. Terner, Maxwell W Hand, Suchita Ganesan, Patrick Walsh, Aisha Greene, Tyler Berkness, Tiantian Lei et al. · 2025 · Imaging Neuroscience
  64. Neuropathologic correlates of cognitive impairment in Alzheimer’s disease with discordant CSF biomarker profiles: co-pathologies in focus
    Konstantinos Ioannou, Richard J. Perrin, Khadidzha Abdullaieva, Marina Blūma, Antoine Leuzy, Konstantinos Poulakis, Dorota Religa, Elena Rodriguez‐Vieitez, Konstantinos Chiotis, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Acta Neuropathologica
  65. The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study
    Marie R. Vermeiren, Joost F. Somsen, Gert Luurtsema, Fransje E. Reesink, Nicolaas A. Verwey, Liesbeth Hempenius, Nelleke Tolboom, Geert Jan Biessels, J. Matthijs Biesbroek, Meike Willemijn Vernooij et al. · 2024 · Alzheimer s Research & Therapy
  66. Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers
    D. Luke Fischer, Lea T. Grinberg, Jared T. Ahrendsen, Thomas G. Beach, Kevin F. Bieniek, Rudolph J. Castellani, Rati Chkheidze, Inma Cobos, Mark L. Cohen, John F. Crary et al. · 2025 · Alzheimer s & Dementia
  67. The challenging concept of preclinical Alzheimer's disease
    David Wallon, Antoine Garnier‐Crussard · 2025 · Revue Neurologique
  68. Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond
    Marina Blūma, Konstantinos Chiotis, Agneta K. Nordberg · 2026 · Current Opinion in Neurology
  69. Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo
    Joseph Therriault, Serge G. Gauthier, Pedro Rosa‐Neto · 2023 · The Journal of Prevention of Alzheimer s Disease
  70. Feasibility of Using Magnetic Resonance Spectroscopy Test Biomarkers to Diagnose Alzheimer's Disease: Systematic Evaluation and Meta-Analysis
    Bo Wei, Yiqin Xu, Ye Du, Jie Zhou, Fangfang Zhong, Chenglong Wu, Yiping Lou · 2024 · Actas Españolas de Psiquiatría
  71. Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome
    Fatih Canan, Neda Wick, Jack M. Raisanen, Dennis K. Burns, Kimmo J. Hatanpaa, Timothy E. Richardson, Charles L. White, Elena V. Daoud · 2025 · Journal of Alzheimer s Disease
  72. Is Alzheimer's disease an individual-centered disease? Hypotheses from the atomic levels up to mathematical models for biological systems
    Maurizio Giorelli, Donatella Accavone, Alfredo De Liso · 2024 · Frontiers in Neurology
  73. Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative disease
    Kaitlin B Casaletto, Rowan Saloner, John Kornak, Adam M. Staffaroni, Saul Villeda, Emily W. Paolillo, Anna M. VandeBunte, Claire J. Cadwallader, Argentina Lario Lago, Julia D Webb et al. · 2024 · Brain Communications
  74. Comparative analysis of the burden of young-onset and late-onset dementia in China from 1990 to 2021: A study based on GBD 2021 data
    Kai Lü, Kai Lü, Zheng-jun Ji · 2025 · The Journal of Prevention of Alzheimer s Disease
  75. Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging
    Shinobu Kawakatsu, Ryota Kobayashi · 2023 · Journal of Alzheimer s Disease
  76. Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment
    Na‐Yeon Jung, Yu-Ri Je, Hong-Gi Ham, Yu Hyun Park, Taeyun Kim, Min-su Go, Hye-In Lee, Da Eun Kim, Myung Jun Lee, Sang Won Seo et al. · 2024 · Alzheimer Disease & Associated Disorders
  77. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer’s Disease Mice
    Andre Direito Goulart Leitao, Brian J. Spencer, Floyd M. Sarsoza, Jennifer Ngolab, Jessica Amalraj, Eliezer Masliah, Chengbiao Wu, Robert A. Rissman · 2023 · Journal of Alzheimer s Disease
  78. Recent advances in fluid and tissue-based biomarkers for use in Parkinson’s disease
    Ravi Rajmohan, Anna Wen, Claire Henchcliffe · 2025 · Expert Review of Neurotherapeutics
  79. Neuropathological correlates of age and sex differences in 18F-flortaucipir PET
    Emma M. Coomans, Ruben A Smith, Daria Pawlik, Kevin Oliveira Hauer, Sebastian Palmqvist, Erik Stomrud, Niklas Mattsson, Cécilia Tremblay, Geidy E. Serrano, Thomas G. Beach et al. · 2026 · Brain
  80. Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer’s disease defined by fluorodeoxyglucose-positron emission tomography
    Takashi Kato, Yukiko Nishita, Rei Otsuka, Yoshitaka Inui, Akinori Nakamura, Yasuyuki Kimura, Kengo Ito, SEAD-J Study Group · 2022 · Frontiers in Aging Neuroscience
  81. Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
    Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, Nilesh Kumar Pandey, Nikita Chhabra, Lomash Banjare, Sourav Basak, Jagadish Singh, Partha Pratim Roy · 2023 · Springer eBooks
  82. CSF α-synuclein aggregation is associated with APOE ε4 and progressive cognitive decline in Alzheimer's disease
    Qiang Qiang, Loren Skudder‐Hill, Tomoko Toyota, Zhe Huang, Wenshi Wei, Hiroaki Adachi · 2025 · Neurobiology of Aging
  83. Identifying sex-specific sub-phenotypes of Alzheimer's disease progression using longitudinal electronic health records
    Weimin Meng, Qiang Yang, Jie Xu, Yu Huang, Cankun Wang, Qianqian Song, Lixin Song, Jiang Bian, Qin Ma, Anjun Ma et al. · 2026 · EBioMedicine
  84. A Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology.
    D. Luke Fischer, William W. Seeley · 2023 · PubMed
  85. The Certain Uncertainty of an Alzheimer Disease Diagnosis
    Gayatri Devi · 2026 · Annals of Internal Medicine
  86. Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer’s disease
    Konstantinos Chiotis, Ganna Blazhenets, David N. Soleimani‐Meigooni, Paul S. S Aisen, Alinda N. Amuiri, Alireza Atri, Laurel A. Beckett, Michael J. Brickhouse, David Glenn Clark, Jeffrey L. Dage et al. · 2026 · medRxiv
  87. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21
    Daneshvar, Daniel H, Nowinski, Christopher J, Abdolmohammadi, Bobak, Luster, Charlotte B, Uretsky, Madeline, Martin, Brett M, Palmisano, Joseph N, Weuve, Jennifer, McClean, Michael D, Cherry, Jonathan D et al. · 2026 · BMJ
  88. A hypergraph neural network for prioritizing Alzheimer’s disease risk genes
    Meng Ma, Chao Deng, Yan Liu, Qingqing Cao, Fang Liu, Yan Zhang · 2025 · Frontiers in Genetics
  89. Impact of cerebral small vessel disease on cognitive outcomes in early age at onset MCI and dementia: Findings from the DIASPORA study
    Jonathan Naftali, Amir Glik, Ruth Eliahou, Gil D Rabninovici, Howar J Rosen, Fanny M. Elahi, Felix Benninger, Ilan Goldberg, Eitan Auriel, Ophir Keret · 2025 · Alzheimer s & Dementia
  90. Putaminal hypermetabolism identifies Lewy body co‐pathology in Alzheimer's disease
    Sung Woo Kang, Seun Jeon, Yeo Ju Kim, Su‐Hee Jeon, Min-Sun Choi, Young‐gun Lee, Byoung Seok Ye, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Alzheimer s & Dementia
  91. Enrichment of patients with concomitant limbic‐predominant age‐related TDP‐43 encephalopathy (LATE) on the Alzheimer's disease continuum using hippocampal volume
    Nidhi S. Mundada, Xueying Lyu, Christopher Brown, Niyousha Sadeghpour, Emily McGrew, Long Xie, Philip A. Cook, James C. Gee, Paul A. Yushkevich, Sandhitsu R. Das et al. · 2025 · Alzheimer s & Dementia
  92. Relationship between age and severity of cognitive impairment at diagnosis for early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI
    Dustin B. Hammers, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone, Sujuan Gao, Laurel A. Beckett, Kala Kirby, Jeffrey L. Dage, Kelly Nicole Holohan Nudelman, Paul S. S Aisen et al. · 2026 · Alzheimer s & Dementia
  93. Defining Alzheimer’s disease: stipulations and the ethics of diagnostic change
    Robin Michalon, Vincent Planche, Maël Lemoine, Lara Keuck, Nicolas Villain · 2026 · Journal of Neurology Neurosurgery & Psychiatry
  94. Identifying patterns of neuropathological diagnoses in medico-legal autopsies – A latent class analysis of 1270 neuropathologically examined cases from Finland
    Xiaojian Keinänen, Paula Katriina Vauhkonen, Petteri Oura · 2026 · Forensic Science Medicine and Pathology
  95. Research progress in neuroimaging of sporadic early-onset Alzheimer’s disease
    Xiang Zhang, Chao Yang · 2026 · Frontiers in Neurology
  96. Effects of α‐synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
    Joseph R. Winer, Melanie J. Plastini, America Romero, Hillary A. Vossler, Isha Sai, Divya Channappa, Carla Abdelnour Ruiz, Marian Shahid, Edward N. Wilson, Hamilton Se‐Hwee Oh et al. · 2026 · Alzheimer s & Dementia
  97. Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease
    Marlene Lin, Konstantinos Chiotis, Piyush Maiti, Jiaxiuxiu Zhang, Ganna Blazhenets, Salma Rocha, Ranjani P. Shankar, Alinda N. Amuiri, Dustin B. Hammers, Ani Eloyan et al. · 2026 · Brain Communications
  98. A paradigm of the diagnosis and treatment for the whole process of Alzheimer’s disease
    Jing Shi, Yifeng Du, Huali Wang, Nan Zhang, Wei Chen, Jingnian Ni, Xianghui Lu, Yongan Sun, Gang Wang, Jun Liu et al. · 2026 · Annals of Medicine
  99. Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration
    Timothy E. Richardson, Jonathan D. Cherry, Shrishtee Kandoi, Susan Karijn Rohde, Madeline Uretsky, Fatima Tuz‐Zahra, Kevin F. Bieniek, Kurt W. Farrell, Marco M. Hefti, Michael B. Miller et al. · 2026 · Acta Neuropathologica
  100. Microbiota and cognitive impairment: Current challenges and future perspectives
    Guillaume Chapelet, Wendy J. Noble, Pascal Derkinderen · 2024 · Journal of Alzheimer s Disease